disparities prevalence pathogenesis progression monoclonal gammopathy undetermined significance multiple myeloma blacks whites abstract marked racial disparity incidence monoclonal gammopathy undetermined significance mgus multiple myeloma threefold increased risk blacks compared whites increased risk africans african americans similarly increased risk monoclonal gammopathies blacks compared whites noted adjusting socioeconomic risk factors suggesting genetic predisposition higher risk multiple myeloma blacks result higher prevalence premalignant mgus stage data suggest blacks higher progression rate mgus myeloma studies emerging suggest baseline cytogenetic characteristics progression differ race contrast increased risk noted blacks studies suggest risk lower racial ethnic groups notably persons japan mexico review literature racial disparity prevalence pathogenesis progression mgus multiple myeloma blacks whites discuss future directions research inform management conditions positively influence patient outcomes 
